Facebook tracking pixel
F41.2
ICD-10-CM
Mixed Anxiety and Depression

Find information on Mixed Anxiety and Depressive Disorder diagnosis, including clinical documentation, ICD-10 codes (F41.2), DSM-5 criteria, medical billing, and healthcare guidelines. Learn about symptoms, treatment options, and best practices for accurately coding and documenting mixed anxiety and depression in clinical settings. This resource provides valuable insights for healthcare professionals, coders, and billers seeking information on Mixed Anxiety Depressive Disorder.

Also known as

Mixed Anxiety-Depressive Disorder
Anxiety Depression
madd

Diagnosis Snapshot

Key Facts
  • Definition : Combined symptoms of anxiety and depression, not meeting criteria for either alone.
  • Clinical Signs : Low mood, worry, fatigue, sleep problems, difficulty concentrating, irritability.
  • Common Settings : Primary care, outpatient clinics, telehealth consultations, mental health services.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC F41.2 Coding
F41.2

Mixed anxiety and depressive disorder

Symptoms of both anxiety and depression are present, but neither predominates.

F40-F48

Neurotic, stress-related and somatoform disorders

Covers various mental disorders including anxiety, phobias, and stress reactions.

F30-F39

Mood affective disorders

Includes depressive and bipolar disorders, characterized by mood disturbances.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Meets criteria for both generalized anxiety and mild to moderate depression?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Mixed anxiety and depression
Generalized anxiety disorder
Major depressive disorder

Documentation Best Practices

Documentation Checklist
  • Document DSM-5 criteria for both anxiety and depression.
  • Specify anxiety and depression symptom duration and severity.
  • Impairment in social, occupational, or other areas must be noted.
  • Rule out medical or substance-induced causes.
  • Include diagnostic code F41.2 (ICD-10-CM).

Coding and Audit Risks

Common Risks
  • Unspecified Anxiety

    Coding F41.9 (Mixed anxiety and depressive disorder) without documenting specific anxiety symptoms risks downcoding or denial. Clarify anxiety type for accurate reimbursement.

  • Insufficient Depression Detail

    Lack of documented depressive symptoms supporting F41.9 can lead to audits and claim rejection. CDI should query for symptom specifics to validate the diagnosis.

  • Medical Necessity of F41.9

    Using F41.9 when separate anxiety and depression diagnoses are clinically supported violates medical necessity guidelines, impacting compliance and reimbursement.

Mitigation Tips

Best Practices
  • ICD-10 F41.2, improve CDI with precise anxiety documentation.
  • DSM-5 300.4, detailed depression symptoms enhance HCC coding.
  • Target symptoms, not labels. Boost compliance, avoid unspecified codes.
  • Track response to therapy for accurate severity, justify medical necessity.
  • Standardized assessments (GAD-7, PHQ-9) aid diagnosis, support E/M levels.

Clinical Decision Support

Checklist
  • 1. Depressed mood AND anxiety documented (ICD-10: F41.2)
  • 2. Symptoms present for >= 2 weeks (clinical validity)
  • 3. Impairment in social/occupational function (DSM-5 criteria)
  • 4. Rule out other medical/substance causes (patient safety)
  • 5. Document symptom severity and frequency (ICD-10 coding)

Reimbursement and Quality Metrics

Impact Summary
  • Reimbursement and Quality Metrics Impact Summary: Mixed Anxiety and Depression
  • ICD-10-CM F41.2 accurate coding maximizes reimbursement.
  • Coding errors impact hospital revenue cycle, denials, and audits.
  • Accurate diagnosis impacts quality reporting for anxiety and depression metrics.
  • Severity documentation influences risk adjustment models and payment.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Quick Tips

Practical Coding Tips
  • Code F41.2 first for MAD
  • Document anxiety and depression
  • Specify predominant symptom if applicable
  • Consider Z codes for stressors
  • Review clinical guidelines for MAD

Documentation Templates

Patient presents with symptoms consistent with a diagnosis of Mixed Anxiety and Depressive Disorder (MADD).  The patient reports experiencing persistent low mood, anhedonia, and difficulty concentrating for the past six months.  Concurrently, the patient endorses excessive worry, feelings of restlessness, irritability, and muscle tension.  These symptoms are present more days than not and cause clinically significant distress and impairment in social and occupational functioning.  The patient denies any history of manic or hypomanic episodes.  Symptoms do not meet the criteria for a major depressive episode or a generalized anxiety disorder individually, but the combined presentation warrants a diagnosis of MADD.  Differential diagnoses considered include Generalized Anxiety Disorder, Major Depressive Disorder, Adjustment Disorder with Mixed Anxiety and Depressed Mood, and medical conditions that can mimic anxiety and depression.  A review of systems was negative for significant findings.  The patient's medical history is unremarkable.  Current medications include over-the-counter analgesics as needed.  Family history is positive for anxiety and depression.  Mental status examination reveals a patient who is alert, oriented, and cooperative, but exhibits a depressed mood and anxious affect.  Thought processes are linear and goal-directed.  No suicidal or homicidal ideation is reported.  Insight and judgment appear intact.  Treatment plan includes initiation of psychotherapy with a focus on cognitive behavioral therapy (CBT) techniques for managing anxiety and depression.  Patient education regarding the nature of MADD, lifestyle modifications such as regular exercise and improved sleep hygiene, and the potential benefits of pharmacotherapy with selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) will be discussed at the next appointment.  Follow-up is scheduled in two weeks to assess treatment response and adjust the plan as needed.  ICD-10 code F41.2 is assigned for Mixed Anxiety and Depressive Disorder.